OUR INVESTORS
Financing Events:
Series D financing round of 13 MUSD was completed in Sept 2017 and led by Forrestal Capital
Series C financing round of 10 MUSD was completed in May 2016 and led by Integer Inc. (NYSE: INT)
Series B financing round of 8 MUSD was completed in September 2014.
Series A financing round of 14 MUSD was completed in April 2012.
Main investors are:
-
BiomedInvest II, managed by BioMedPartners in Basel, Switzerland (www.biomedvc.com)
-
BB Biotech Ventures III, managed by BB Biotech in Kuesnacht, Switzerland (www.bbbiotechventures.com)
-
Initiative Capital Romandie, managed by Defi Gestion in Lausanne, Switzerland (www.defigestion.com)
-
BV5 FPCI, managed by Kreaxi in Paris, France (http://www.kreaxi.com/en/)
-
Integer Inc. (NYSE: INT) (www.integer.net)